|
Radiology HomeDepartment OverviewFacultyResidencyFellowshipsNeuroradiologyRochester CommunityLinks |
|
Neuroradiology Case of the Week
Case 133 Loris F. Cedeno, MD, Jeevak Almast, MD, Clinical Presentation: A nine-day-old male with a history of ornithine transcarbamylase deficiency presented with hyperammonemia and diffuse change on EEG. This study was performed for clinical suspicion for intracranial abnormality. Radiological Findings: There are symmetric multiple areas of hyperintensity on diffusion-weighted images in bilateral cerebral peduncles, basal ganglia, internal capsule, and white matter adjacent to the perirolandic cortex. Some of these areas are also hyperintense on FLAIR images (Figs 1-4).
Diagnosis: Neonatal hyperammonemic encephalopathy secondary to proximal urea cycle disorder Discussion: The urea cycle requires proper functioning of five different types of enzymes to convert excessive ammonium into urea, which is excreted in the urine. Our patient had ornithine transcarbamylase deficiency which is the most common form of urea cycle enzyme defect. This defect results in failure of condensation of ornithine with carbamyl phosphate which leads to high levels of plasma ammonium and high urine orotic acid levels. Full-term neonates appear healthy for the first 24-48 hours of life and then develop progressive lethargy, hypothermia and apnea. The presence of high levels of ammonia results in the conversion of large amounts of glutamate to glutamine by glutamine synthetase; this occurs mainly in the astrocytes. It is thought that the accumulation of large quantities of glutamine cause changes in intracellular osmolality and result in subsequent astrocyte swelling, brain edema, intracranial hypertension, and cerebral hypoperfusion. Images reveal abnormal signal in bilateral lentiform nuclei as well as in the perirolandic and insular cortices. Our case demonstrates similar findings as those reported previously in the literature. In addition, MR spectroscopy will demonstrate markedly increased peaks at 2.05-2.55 and 3.68-3.85 ppm which are assigned to glutamate/glutamine complex. References:
|
|||||||||||||||||||||||||||
|
©Copyright University of Rochester Medical Center, 1999-2006. Disclaimer. For questions or suggestions concerning the content of these pages, contact the URMC Webmaster. |
|||||||||||||||||||||||||||||